| 1L | First line |
| 2L | Second line |
| BRAF/MEKi | BRAF/MEK inhibitor |
| CI | Confidence interval |
| CTLA4 | Cytotoxic T-lymphocyte-associated protein 4 |
| HR | Hazard ratio |
| ICI | Immune checkpoint inhibitor |
| LAG3 | Lymphocyte activation gene 3 |
| MUP | Melanoma of unknown primary |
| NR | Not reached |
| OS | Overall survival |
| PD1 | Programmed cell death protein 1 |
| PFS | Progression-free survival |
| RFS | Relapse-free survival |
| TT | Targeted therapy |
Official websites use .gov
A
.gov website belongs to an official
government organization in the United States.
Secure .gov websites use HTTPS
A lock (
) or https:// means you've safely
connected to the .gov website. Share sensitive
information only on official, secure websites.